RLAY

Relay Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · RLAY

All alert types
18.35 USD -1.12 -5.75%
As of Oct 30, 2026 Extended hours 18.22 -0.69%
Bid
18.33 × 2
Ask
18.34 × 2
18.01 Day range 19.48
6.05 52-week range 20.75
YTD
+116.90%
1 year
+150.00%
Open
19.09
Prev close
19.47
Mkt cap
4.02B
Vol
3.60M
Avg vol
2.73M
EPS
-1.56
P/E
0.00
Div yield
0.00%
More statistics
Low
18.01
High
19.48
Forward P/E
-11.28
Beta
1.73
Short ratio
13.49
Inst. own
110.88%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
18.54
200-d avg
14.95
1y target
27.58

5D chart

Chart tools
Interval
RLAY five-day price chart17.818.419.019.620.2Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

28.13 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -5.3×
FY 2018: -1.8×FY 2019: -2.3×FY 2020: -16.2×FY 2021: -8.0×FY 2022: -5.8×FY 2023: -3.9×FY 2024: -1.7×FY 2025: -5.3×
FY 2018 5y median -5.3× FY 2025
P/S 94.5×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 45.3×FY 2021: 965×FY 2022: 1214×FY 2023: 52.8×FY 2024: 58.8×FY 2025: 94.5×
FY 2018 5y median 94.5× FY 2025
P/B 2.6×
FY 2018: -0.8×FY 2019: -0.8×FY 2020: 4.9×FY 2021: 3.3×FY 2022: 1.8×FY 2023: 1.8×FY 2024: 0.8×FY 2025: 2.6×
FY 2018 5y median 1.8× FY 2025
P/FCF -6.2×
FY 2018: -1.9×FY 2019: -2.0×FY 2020: -35.8×FY 2021: -37.5×FY 2022: -7.0×FY 2023: -4.4×FY 2024: -2.3×FY 2025: -6.2×
FY 2018 5y median -6.2× FY 2025
EV/EBITDA -5.1×
FY 2018: 7.0×FY 2019: -1.6×FY 2020: -63.5×FY 2021: -11.9×FY 2022: -5.2×FY 2023: -3.4×FY 2024: -1.3×FY 2025: -5.1×
FY 2018 5y median -5.1× FY 2025
EV/Sales 91.2×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 40.2×FY 2021: 880×FY 2022: 1146×FY 2023: 49.3×FY 2024: 51.2×FY 2025: 91.2×
FY 2018 5y median 91.2× FY 2025
FCF Yield -16.2%
FY 2018: -52.6%FY 2019: -49.4%FY 2020: -2.8%FY 2021: -2.7%FY 2022: -14.2%FY 2023: -22.6%FY 2024: -42.7%FY 2025: -16.2%
FY 2018 5y median -16.2% FY 2025

Profitability

Gross Margin 76.8%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 95.7%FY 2021: -5492.2%FY 2022: -17496.3%FY 2023: -1177.6%FY 2024: -3052.2%FY 2025: 76.8%
FY 2018 5y median -3052.2% FY 2025
Operating Margin -1971.6%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -67.5%FY 2021: -12040.2%FY 2022: -21670.9%FY 2023: -1460.1%FY 2024: -3722.1%FY 2025: -1971.6%
FY 2018 5y median -3722.1% FY 2025
Net Margin -1800.6%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -63.4%FY 2021: -12012.9%FY 2022: -21036.1%FY 2023: -1338.7%FY 2024: -3374.7%FY 2025: -1800.6%
FY 2018 5y median -3374.7% FY 2025
ROE -48.8%
FY 2018: 44.0%FY 2019: 36.9%FY 2020: -6.9%FY 2021: -40.5%FY 2022: -30.6%FY 2023: -45.5%FY 2024: -43.4%FY 2025: -48.8%
FY 2018 5y median -43.4% FY 2025
ROIC -50.5%
FY 2018: -11.8%FY 2019: -22.0%FY 2020: -7.1%FY 2021: -37.0%FY 2022: -28.8%FY 2023: -45.6%FY 2024: -45.1%FY 2025: -50.5%
FY 2018 5y median -45.1% FY 2025
ROA -44.5%
FY 2018: -11.4%FY 2019: -16.9%FY 2020: -6.6%FY 2021: -36.1%FY 2022: -26.4%FY 2023: -40.5%FY 2024: -38.8%FY 2025: -44.5%
FY 2018 5y median -38.8% FY 2025

Growth (YoY)

Revenue 53.4%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -96.3%FY 2022: -54.4%FY 2023: 1749.8%FY 2024: -60.8%FY 2025: 53.4%
FY 2018 FY 2025
Operating Income 18.7%
FY 2018: 0.0%FY 2019: -68.5%FY 2020: 33.6%FY 2021: -553.6%FY 2022: 17.9%FY 2023: -24.6%FY 2024: 0.1%FY 2025: 18.7%
FY 2018 FY 2025
EPS (diluted) 31.8%
FY 2018: 0.0%FY 2019: 20.9%FY 2020: 83.5%FY 2021: -49.2%FY 2022: 32.2%FY 2023: -7.7%FY 2024: 15.4%FY 2025: 31.8%
FY 2018 FY 2025
Free Cash Flow 6.1%
FY 2018: 0.0%FY 2019: -61.8%FY 2020: -40.9%FY 2021: 25.4%FY 2022: -206.3%FY 2023: -27.6%FY 2024: 17.5%FY 2025: 6.1%
FY 2018 FY 2025

Financial Health

Current Ratio 22.6×
FY 2018: 61.8×FY 2019: 30.1×FY 2020: 56.5×FY 2021: 40.1×FY 2022: 16.0×FY 2023: 25.4×FY 2024: 16.0×FY 2025: 22.6×
FY 2018 5y median 22.6× FY 2025
Quick Ratio 22.6×
FY 2018: 61.8×FY 2019: 30.1×FY 2020: 56.5×FY 2021: 40.1×FY 2022: 15.8×FY 2023: 25.4×FY 2024: 16.0×FY 2025: 22.6×
FY 2018 5y median 22.6× FY 2025
Debt / Equity 0.1×
FY 2018: -0.0×FY 2019: -0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2018: 8.8×FY 2019: 0.2×FY 2020: 8.1×FY 2021: 1.2×FY 2022: 0.3×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.2×
FY 2018 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31